Overview of Drugs Approved, in Trial and in the Pipeline for Medullary Thyroid Cancer
Matthew D. Ringel, MD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013
Home » 2013 Overview of Drugs Approved, in Trial and in the Pipeline for Medullary Thyroid Cancer
Overview of Drugs Approved, in Trial and in the Pipeline for Medullary Thyroid Cancer
Matthew D. Ringel, MD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013
An Update on Novel Therapies for Advanced Thyroid Cancer:
When to Start and What to Use
Sponsored by a continuing medical education grant from AstraZeneca
Chair: Mimi Hu
Overview of Drugs Approved, in Trial and in the Pipeline for Medullary Thyroid Cancer
Matthew D. Ringel, MD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013